HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells
Authors
Keywords
HDAC2, IL-6, Osteosarcoma, p65, IKK-β
Journal
CELL BIOLOGY AND TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-01
DOI
10.1007/s10565-019-09459-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma
- (2018) Hitoshi Itoh et al. ONCOGENE
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin
- (2016) Li Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity
- (2016) Zhiqiang Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation
- (2016) Zhantao Deng et al. International Journal of Biological Sciences
- Immunotherapeutic Approaches to Sarcoma
- (2015) Melissa Burgess et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure
- (2015) Hikmet Nural-Guvener et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
- (2015) Xiaodong Mu et al. Biomed Research International
- Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans
- (2014) S. W. Choi et al. BLOOD
- Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?
- (2014) Anthony J. Mutsaers et al. BONE
- Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review
- (2014) N C Daw et al. BRITISH JOURNAL OF CANCER
- Targeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACs
- (2014) Katherine B. Schuetze et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Epigenetic alterations in osteosarcoma: promising targets
- (2014) Binghao Li et al. MOLECULAR BIOLOGY REPORTS
- STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF- B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
- (2014) M. Xiang et al. Science Signaling
- Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
- (2013) S S Roy et al. ONCOGENE
- Effect of the cytokine levels in serum on osteosarcoma
- (2013) Hong Xiao et al. TUMOR BIOLOGY
- Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells
- (2012) Dong-Dong Cheng et al. Asian Pacific Journal of Cancer Prevention
- STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
- (2012) Bing Tu et al. CANCER LETTERS
- Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma
- (2012) Idriss M. Bennani-Baiti et al. HUMAN PATHOLOGY
- Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma
- (2012) D Kesanakurti et al. ONCOGENE
- HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma
- (2011) Cheng-Chi Chang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin
- (2011) Lei Zhang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination
- (2011) Ying Chen et al. NATURE NEUROSCIENCE
- Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
- (2010) Kathrin Mutze et al. ANNALS OF SURGICAL ONCOLOGY
- The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin
- (2010) Luke A. Wittenburg et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma
- (2010) I. Pasic et al. CANCER RESEARCH
- The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammation
- (2010) A. R. Brasier CARDIOVASCULAR RESEARCH
- Targeting the osteosarcoma cancer stem cell
- (2010) Valerie A Siclari et al. Journal of Orthopaedic Surgery and Research
- HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA
- (2009) P Fritsche et al. GUT
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now